Skip to content
Bold Club Central

The Zimbabwean Government Rejects ‘One-Sided’ American Health Aid Package Due to Data Apprehensions

Health funding image
The offered American funding would have supported programmes for HIV/Aids treatment and prevention, TB, and malaria.

Zimbabwe has declined a substantial US healthcare agreement worth 367 million US dollars (£272m) over five years because of Washington's demand for sensitive data.

This rejection came to light after a government memo dated December was leaked, indicating that Head of State Emmerson Mnangagwa deemed the arrangement was "lopsided".

An official spokesperson later explained that the United States was seeking genetic material for research and profit but refused to guarantee the benefits from any future medical innovations.

"We will now turn to the challenging and unfortunate process of ending our health aid in Zimbabwe," remarked US ambassador to Zimbabwe Pamela Tremont publicly.

Her embassy said the US had donated over $1.9bn as health assistance to Zimbabwe during the past two decades.

A doctors' association in Zimbabwe has urged continued negotiations to find a deal suitable to both sides so the nation's critical HIV treatment initiative can proceed.

Wider Implications

This development follows a similar case in neighbouring Kenya, where a court blocked a related health funding agreement following legal challenges were filed about the security of citizens' health data.

Since returning to the presidency recently, US President Donald Trump has slashed overseas assistance and closed the key foreign aid agency.

USAID had managed aid for the US government, but Trump argued its spending was "inefficient" and his government was seeking direct bilateral deals to enhance transparency and responsibility.

Based on statements, 16 African countries have to date agreed to similar health pacts, constituting more than $18.3bn in committed funds.

Details of the Rejected Agreement

The money for Zimbabwe was intended to funded "HIV/Aids treatment and prevention, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.

"We believe this collaboration could have provided extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children currently on antiretroviral therapy through American-funded programmes," the Ambassador said.

However, government spokesperson Nick Mangwana maintained the proposed deal was "asymmetrical".

"The proposal required Zimbabwe to share its genetic material and health information for a long time, without any corresponding promise of access to any medical innovations – such as vaccines, diagnostics, or treatments – that might result from that provided information," Mangwana explained.

"Put simply, our nation would provide the basic resources for scientific discovery without any assurance that the end products would be available to our population should a future health crisis emerge."

National Interest and International Frameworks

He also pointed out that the US's withdrawal from the global health body and its pursuit of bilateral health agreements were undermining frameworks already set up via the global health agency.

Mangwana cited its Pathogen Access and Benefit Sharing scheme created to deal with potential pandemics.

"This system is intended to ensure that when a country provides its data, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised exclusively by those with the resources to create them."

These objections regarding the US deal "should not be misconstrued as opposition to America," he added.

"We are open to ongoing dialogue with our US partners on how subsequent collaboration could be structured in a manner that honours the sovereignty and interests of each country."

Health Experts Reaction

A leading public health body expressed it acknowledged the government's concerns, but urged that talks must proceed since much of the nation's Aids initiatives depended on foreign aid.

"If specific concerns exist, including those involving data governance or implementation frameworks, these can often be addressed via detailed discussion and negotiated safeguards," the group said.

The halted deal highlights the continuing challenges between receiving vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.

Written by

Kathleen Giles

A seasoned business strategist with over 15 years of experience helping startups scale and innovate in competitive markets.

Bold Club Central

Type to search articles.